Literature DB >> 3523885

Serology of liver transplantation in the rat. I. Alloantibody responses and evidence for tolerance in a nonrejector combination.

N Kamada, T Shinomiya.   

Abstract

The antibody response against class I and class II RT1 antigens has been studied in PVG rats grafted with DA liver. In this nonrejector combination, liver grafts survive permanently in all normal recipients and in about 50% of recipients presensitized by a DA skin graft, with concurrent induction of transplant tolerance for other DA organs and skin. Using a two-stage radioimmunoassay, the anti-class I (RT1Aa) levels in sera of normal PVG recipients of DA liver grafts were found to be low (maximal titer 1:50 serum dilution or less); after peaking at 2 weeks posttransplantation, they diminished to background levels by 6 weeks. The anti-RT1Aa response showed a close parallel to cell-mediated rejection events in the liver graft recipients. In contrast, anti-class II (RT1Ba/Da) responses reached much higher titers (over 1:1000), which were maintained for several weeks before declining after 4 months. Similar observations were made in presensitized recipients. The induction of tolerance in the alloantibody response was indicated by the inability of DA skin grafts to restimulate anti-RT1 antibody in liver recipients. The observations support the picture of "split tolerance" indicated by previous cellular studies in this combination.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3523885     DOI: 10.1097/00007890-198607000-00002

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  8 in total

1.  Immunological tolerance induced by liver grafting in the rat: splenic macrophages and T cells mediate distinct phases of immunosuppressive activity.

Authors:  S Yoshimura; S Gotoh; N Kamada
Journal:  Clin Exp Immunol       Date:  1991-07       Impact factor: 4.330

2.  Mechanisms in passive enhancement of cardiac and renal allografts by serum from liver-grafted rats.

Authors:  A Yamaguchi; N Kamada
Journal:  Immunology       Date:  1991-01       Impact factor: 7.397

Review 3.  [Immunologic tolerance after experimental liver transplantation].

Authors:  M Knoop; U Neumann; P Neuhaus
Journal:  Langenbecks Arch Chir       Date:  1995

4.  Liver graft induced donor specific unresponsiveness without class I and/or class II antigen differences.

Authors:  S Qian; H Sun; A J Demetris; F Fu; T E Starzl; J J Fung
Journal:  Transplant Proc       Date:  1993-02       Impact factor: 1.066

5.  The role of antibodies in liver graft-induced tolerance in mice: passive transfer of serum and effect of recipient B-cell depletion.

Authors:  U Dahmen; H Sun; Y Li; F Fu; A J Demetris; T E Starzl; S Qian; J J Fung
Journal:  Transplant Proc       Date:  1995-02       Impact factor: 1.066

6.  Five-year histological and serological follow-up of operationally tolerant pediatric liver transplant recipients enrolled in WISP-R.

Authors:  Sandy Feng; Anthony J Demetris; Katharine M Spain; Sai Kanaparthi; Bryna E Burrell; Udeme D Ekong; Estella M Alonso; Philip Rosenthal; Laurence A Turka; David Ikle; Nadia K Tchao
Journal:  Hepatology       Date:  2016-07-27       Impact factor: 17.425

7.  De novo donor-specific HLA antibodies decrease patient and graft survival in liver transplant recipients.

Authors:  H Kaneku; J G O'Leary; N Banuelos; L W Jennings; B M Susskind; G B Klintmalm; P I Terasaki
Journal:  Am J Transplant       Date:  2013-06       Impact factor: 8.086

8.  De Novo Donor Specific Antibody and Long-Term Outcome After Liver Transplantation: A Systematic Review and Meta-Analysis.

Authors:  Zahra Beyzaei; Bita Geramizadeh; Zahra Bagheri; Sara Karimzadeh; Alireza Shojazadeh
Journal:  Front Immunol       Date:  2020-12-23       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.